Clinical trials
Lung Neoplasms trials in Italy with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Institute of Oncology | 6 |
| Istituto Clinico Humanitas | 6 |
| Istituto Nazionale per lo Studio e la Cura dei Tumori | 3 |
| University of Turin, Italy | 3 |
| Università Politecnica delle Marche | 2 |
| Azienda Ospedaliero Universitaria Maggiore della Carita | 1 |
| Azienda Sanitaria-Universitaria Integrata di Udine | 1 |
| Consorzio Oncotech | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 40 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Melanoma | 6 |
| Neoplasms | 5 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Lung Diseases | 3 |
| Breast Neoplasms | 2 |
| Cardiovascular Diseases | 2 |
| Head and Neck Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.